Story · Public Health
Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation
2 outlets · first reported by PLOS Medicine 6d ago · latest 6d ago · 5 hours of coverage · 2 countries
Coverage, in order
-
6d agoGlobal return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation
by Hallie Benjamin, Gregory Barnsley, Oliver J. Watson, Mark Jit Background COVID-19 vaccines played a critical role in reducing global health burden during the COVID-19 pandemic, but their rapid development required extraordinary effort. This study aims to evaluate their global…
-
6d ago
The economic benefits of the covid vaccines may be double what we thoughtThe covid-19 vaccines were costly to produce, but paid for themselves many times over Paul Christian Gordon / Alamy The covid-19 vaccines may have provided health and economic benefits worth up to $64.3 trillion in the first year alone – almost double an earlier estimate. Previously, researchers…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.